Unexpected and abnormally low HDL cholesterol levels on combination hypolipidemic therapy

J Assoc Physicians India. 2009 Feb:57:180-1.

Abstract

In general, Indians have low HDL cholesterol levels. Fenofibrate, a drug widely used in the treatment of hypertriglyceridemia, usually also increases HDL cholesterol. There have been a few reports in the literature of a paradoxical decrease in serum HDL-cholesterol in patients treated with fenofibrate, either alone or in combination with a statin. We report three cases of paradoxical decrease in serum HDL-cholesterol in type 2 diabetic patients treated with a statin-fenofibrate combination.

Publication types

  • Case Reports

MeSH terms

  • Atorvastatin
  • Cholesterol, HDL / blood*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / therapy
  • Drug Therapy, Combination
  • Dyslipidemias / blood
  • Dyslipidemias / complications
  • Dyslipidemias / drug therapy*
  • Fenofibrate / administration & dosage*
  • Heptanoic Acids / administration & dosage*
  • Humans
  • Hypolipidemic Agents / administration & dosage*
  • Male
  • Middle Aged
  • Pyrroles / administration & dosage*

Substances

  • Cholesterol, HDL
  • Heptanoic Acids
  • Hypolipidemic Agents
  • Pyrroles
  • Atorvastatin
  • Fenofibrate